EZbra Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $3M
Latest Deal Amount

EZbra General Information

Description

Developer of a medical device designed to provide breast wound dressings. The company's product is a all in one advanced breast dressing, proprietary sterile and disposable bra that fits perfectly to any breast formation and covers, absorb wound exudates, apply various amounts of compression, anchor implants and stabilize drains, enabling women with breast surgeries to recover in a quick and safe manner.

Contact Information

Website
www.ezbra.net
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Primary Office
  • Brenner Street 5
  • Tel Aviv
  • Israel

EZbra Timeline

2018201920202021
Financing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

EZbra Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Angel (individual) 01-Dec-2018 $3M 00.000 Completed Generating Revenue
4. Seed Round 01-Jul-2018 00000 00.000 Completed Generating Revenue
3. Angel (individual) 24-Jul-2017 Cancelled Startup
2. Seed Round 24-Jul-2017 $2M $2.12M Completed Startup
1. Angel (individual) 01-Jul-2014 $125K $125K Completed Startup
To view EZbra’s complete valuation and funding history, request access »

EZbra Executive Team (5)

Name Title Board Seat Contact Info
Efrat Roman Founder & Chief Executive Officer
Rotem Palash Chief Financial Officer & Chief Operating Officer
Yael Gibor Chief Technology Officer
Sherrell Aston Advisory Board Member
Yaffa Krindel Chairman
To view EZbra’s complete executive team members history, request access »

EZbra Board Members (1)

Name Representing Role Since
Yaffa Krindel EZbra Chairman 000 0000
To view EZbra’s complete board members history, request access »